Literature DB >> 22476388

Linkage disequilibrium between the CYP2C19*17 allele and other clinically important CYP2C allelic variants in a healthy Scandinavian population.

Rasmus Steen Pedersen, Mette Marie Hougaard Christensen, Kim Brøsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22476388     DOI： 10.1007/s00228-012-1272-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms.

Authors:  Umit Yasar; Stefan Lundgren; Erik Eliasson; Anna Bennet; Björn Wiman; Ulf de Faire; Anders Rane
Journal:  Biochem Biophys Res Commun       Date:  2002-11-22       Impact factor: 3.575

3.  Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation.

Authors:  Matthew Stephens; Paul Scheet
Journal:  Am J Hum Genet       Date:  2005-01-31       Impact factor: 11.025

4.  Linkage disequilibrium between the CYP2C19*17 and CYP2C8*2 alleles in populations of African descent.

Authors:  Guilherme Suarez-Kurtz
Journal:  Eur J Clin Pharmacol       Date:  2010-10-03       Impact factor: 2.953

5.  Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.

Authors:  Rasmus S Pedersen; Charlotte Brasch-Andersen; Sarah C Sim; Troels K Bergmann; Jónrit Halling; Maria S Petersen; Pál Weihe; Hege Edvardsen; Vessela N Kristensen; Kim Brøsen; Magnus Ingelman-Sundberg
Journal:  Eur J Clin Pharmacol       Date:  2010-07-28       Impact factor: 2.953
  5 in total
  4 in total

1.  Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial.

Authors:  Mette Marie H Christensen; Kurt Højlund; Ole Hother-Nielsen; Tore B Stage; Per Damkier; Henning Beck-Nielsen; Kim Brøsen
Journal:  Diabetologia       Date:  2015-08-14       Impact factor: 10.122

2.  Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers.

Authors:  Mette Marie Hougaard Christensen; Kurt Højlund; Ole Hother-Nielsen; Tore Bjerregaard Stage; Per Damkier; Henning Beck-Nielsen; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2015-05-05       Impact factor: 2.953

3.  Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone.

Authors:  Tore Bjerregaard Stage; Rasmus Steen Pedersen; Per Damkier; Mette Marie Hougaard Christensen; Søren Feddersen; John Teilmann Larsen; Kurt Højlund; Kim Brøsen
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

Review 4.  PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.

Authors:  Christina L Aquilante; Mikko Niemi; Li Gong; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-12       Impact factor: 2.089
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.